An update on palliative therapy in advanced prostate cancer

被引:0
作者
Ozdedeli, Kaan [1 ]
Kuyumcuoglu, Ugur [1 ]
机构
[1] Trakya Univ, Tip Fak, Urol Anabilim Dali, Edirne, Turkey
来源
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2014年 / 13卷 / 01期
关键词
prostate cancer; palliative therapy; complications; castration resistant;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advanced prostat cancer is a progressive and debilitating disease which may lead to complex physical and emotional complications due to disease's progression and treatment morbidities. Physical complications like pain, skeletal complications, hot flushes, fatique, gastrointestinal and lower urinary dysfunction as well as the emotional problems may result in severe alterations in disease progresion and Qol parameters. Current approach favors an early and more meticilous palliative care, along with the primary treatment of the disease. Multidisiplinary treatment must be the choice in this stage of the disease which lacks significant evidence based data due to its complex symptomatology and deficiencies in current health systems. Patient's education, communication, emotional support and periodical monitorisation of quality of life are important issues that have to be included necessarily in advanced prostate cancer.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 51 条
[1]   Guidance on the use of bisphosphonates in solid tumours:: recommendations of an international expert panel [J].
Aapro, M. ;
Abrahamsson, P. A. ;
Body, J. J. ;
Coleman, R. E. ;
Colomer, R. ;
Costa, L. ;
Crino, L. ;
Dirix, L. ;
Gnant, M. ;
Gralow, J. ;
Hadji, P. ;
Hortobagyi, G. N. ;
Jonat, W. ;
Lipton, A. ;
Monnier, A. ;
Paterson, A. H. G. ;
Rizzoli, R. ;
Saad, F. ;
Thuerlimann, B. .
ANNALS OF ONCOLOGY, 2008, 19 (03) :420-432
[2]  
Aaronson NK, J NATL CANC I, V993, P365
[3]   Health-related quality of life among patients with metastatic prostate cancer [J].
Albertsen, PC ;
Aaronson, NK ;
Muller, MJ ;
Keller, SD ;
Ware, JE .
UROLOGY, 1997, 49 (02) :207-216
[4]   SICKNESS IMPACT PROFILE - VALIDATION OF A HEALTH STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
POLLARD, WE ;
MARTIN, DP ;
GILSON, BS .
MEDICAL CARE, 1976, 14 (01) :57-67
[5]   Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets [J].
Chi, Kim N. ;
Bjartell, Anders ;
Dearnaley, David ;
Saad, Fred ;
Schroeder, Fritz H. ;
Sternberg, Cora ;
Tombal, Bertrand ;
Visakorpi, Tapio .
EUROPEAN UROLOGY, 2009, 56 (04) :594-605
[6]   Emerging drugs for major depressive disorder [J].
Connolly, Kevin Ryan ;
Thase, Michael E. .
EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (01) :105-126
[7]  
Cookson S.M, 2013, CASTRATION RESISTANT
[8]   Baseline quality of life of patients with advanced prostate cancer [J].
Curran, D ;
Fossa, S ;
Aaronson, N ;
Kiebert, G ;
Keuppens, E ;
Hall, R .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1809-1814
[9]   Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials [J].
Dearnaley, David P. ;
Mason, Malcolm D. ;
Parmar, Mahesh K. B. ;
Sanders, Karen ;
Sydes, Matthew R. .
LANCET ONCOLOGY, 2009, 10 (09) :872-876
[10]   A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 trial) [J].
Dearnaley, DP ;
Sydes, MR ;
Mason, MD ;
Stott, M ;
Powell, CS ;
Robinson, ACR ;
Thompson, PM ;
Moffat, LE ;
Naylor, SL ;
Parmar, MKB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (17) :1300-1311